Sam Brusco, Associate Editor04.07.22
Senseonics and commercialization partner Ascensia Diabetes Care have achieved the first commercial implantation of the Eversense E3 implantable continuous glucose monitor (CGM), marking its launch in the U.S. The Eversense E3 sensor was approved by the U.S. Food and Drug Administration (FDA) in February.
“The accuracy, duration and implantable form of Eversense E3 combine to provide diabetes patients confidence and convenience never available previously,” Bantwal S. Baliga, MD: MRCP (U.K.), Director of East Alabama Endocrinology, and the first physician to insert the extended life sensor told the press. “This next-generation implantable system has been designed with patients in mind by offering 6-months of sensor life. It also offers unique benefits like discrete on-body vibratory alerts through a removable transmitter that provides patients wear time flexibility without ever having to waste a sensor. It is an important offering for patients wanting accuracy, protection, and convenience.”
According to the company Eversense E3 is the longest lasting CGM available, with a six-month sensor wear time. The fully implantable fluorescence-based sensor has a removable smart transmitter for discreet on-body vibration alerts and data transmission to a mobile app.
Eversense E3 also requires fewer calibrations compared to previous Eversense generations.
“The accuracy, duration and implantable form of Eversense E3 combine to provide diabetes patients confidence and convenience never available previously,” Bantwal S. Baliga, MD: MRCP (U.K.), Director of East Alabama Endocrinology, and the first physician to insert the extended life sensor told the press. “This next-generation implantable system has been designed with patients in mind by offering 6-months of sensor life. It also offers unique benefits like discrete on-body vibratory alerts through a removable transmitter that provides patients wear time flexibility without ever having to waste a sensor. It is an important offering for patients wanting accuracy, protection, and convenience.”
According to the company Eversense E3 is the longest lasting CGM available, with a six-month sensor wear time. The fully implantable fluorescence-based sensor has a removable smart transmitter for discreet on-body vibration alerts and data transmission to a mobile app.
Eversense E3 also requires fewer calibrations compared to previous Eversense generations.